The LUVEN screening test method created by scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy. The LUVEN technology allows diagnosing the disease at its early stages , thus, giving a chance to thousands of people to prevent its further development.
|Token Sale Start Date||8th Dec 2017|
|Token Sale End Date||28th Feb 2018|
|Latest Tweets||Tweets by LuvenmedI|